Skip to content
Screener
Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$83.72M-17.7%-$92.56M-33.6%-$88.91M-51.5%-$73.93M-42.4%-$71.13M-118%
$33K-28.3%$39K-17.0%$28K-40.4%$19K-79.3%$46K-57.0%
$11.31M+45.5%$17.11M+94.8%$9.94M+15.9%$7.45M-40.1%$7.77M+32.2%
-$77.54M-41.8%-$86.15M-62.5%-$76.33M-36.0%-$65.06M-137%-$54.68M-100%
$245K+338%$62K$56K
-$344.28M-574%-$328.39M-2,908%$50.41M$0+100%
$4.57M-84.0%$609.43M+1,023%$612.52M+438%$6.76M+370%$28.63M-86.8%
$179M+459%$207.8M+345%-$7.89M-134%-$8.15M
-$77.79M-42.1%-$86.21M-62.6%-$76.33M-36.0%-$65.06M-137%-$54.73M-101%

FAQ

How much cash does Praxis Precision Medicines, Inc. generate?
Praxis Precision Medicines, Inc. (PRAX) generated -$305.1M in operating cash flow over the trailing twelve months.
What is Praxis Precision Medicines, Inc.'s free cash flow?
After $363.0K of capital expenditures, Praxis Precision Medicines, Inc.'s free cash flow was -$305.4M over the trailing twelve months, down 59.6% year over year.
Where does Praxis Precision Medicines, Inc.'s cash flow data come from?
Every line is extracted from Praxis Precision Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.